Prem Krishan Tambar, M.D

Medicare Part B Activity

Reported 30,978 Medicare fee-for-service service lines in 2024.

Activity Percentile

98.6%

Rank by Services

9 of 665

Total Services

30,978

Est. Allowed Value

$957,554.14

Dataset Year

2024

Drug Code Share

96.4%

Estimated allowed value reflects Medicare fee-for-service allowed amounts only. It does not include Medicare Advantage, commercial insurance, cash-pay services, or employment compensation.

Peers are grouped by the broader Internal Medicine classification rather than the exact subspecialty label shown elsewhere on the page.

Drug-related HCPCS codes make up 96.4% of reported Medicare services, so the claim mix is dominated by administered-drug billing lines.

Top Clinical Services

• 99214: Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more

  318 services | $38,621.59

• 96365: Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

  273 services | $15,923.31

• 96415: Administration of chemotherapy into vein, each additional hour

  193 services | $4,999.59

• G2211: Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's

  162 services | $2,531.39

• 96413: Administration of chemotherapy into vein, 1 hour or less

  107 services | $12,868.57

Common Drug-Related Codes

• J0129: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

  15,406 services | $656,434.74

• J1602: Injection, golimumab, 1 mg, for intravenous use

  11,050 services | $127,207.74

• J1745: Injection, infliximab, excludes biosimilar, 10 mg

  2,870 services | $90,178.42